M. C. Ezgu Et Al. , "Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression," TURKISH NEUROSURGERY , vol.31, no.3, pp.447-459, 2021
Ezgu, M. C. Et Al. 2021. Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression. TURKISH NEUROSURGERY , vol.31, no.3 , 447-459.
Ezgu, M. C., Kural, C., Simsek, G. G., Kaygin, P., OĞUZTÜZÜN, S., Kirik, A., ... Yasar, S.(2021). Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression. TURKISH NEUROSURGERY , vol.31, no.3, 447-459.
Ezgu, Mehmet Et Al. "Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression," TURKISH NEUROSURGERY , vol.31, no.3, 447-459, 2021
Ezgu, Mehmet C. Et Al. "Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression." TURKISH NEUROSURGERY , vol.31, no.3, pp.447-459, 2021
Ezgu, M. C. Et Al. (2021) . "Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression." TURKISH NEUROSURGERY , vol.31, no.3, pp.447-459.
@article{article, author={Mehmet Can Ezgu Et Al. }, title={Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression}, journal={TURKISH NEUROSURGERY}, year=2021, pages={447-459} }